Assessing The Future Of Coronary Stenting: An Interview With Dean J. Kereiakes, MD
Executive Summary
Dean Kereiakes, MD, a PI for Abbott Vascular’s ABSORB III US pivotal trial, discusses the future of coronary stenting and provides his unique perspective on the potential role of bioresorbable vascular scaffolds for the treatment of coronary artery disease.